Changmao Biochemical Engineering Company Limited (00954.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−144.2x

Market Cap

HKD 120.22M

MomentumView details →

1D Return

+0.89%

YTD Return

−20.35%

RSI (14)

14.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−144.2x

Market Cap

HKD 120.22M

RSI (14)

14.6

MomentumView details →

1D Return

+0.89%

YTD Return

−20.35%

ProfitabilityView details →

Gross Margin

3.97%

Net Margin

−11.82%

EBITDA Margin

−0.35%

ROE (TTM)

−26.12%

ROA (TTM)

−11.44%

Asset Turnover

0.95x

GrowthView details →

Revenue YoY

−16.49%

EPS YoY

—

FCF YoY

+75.09%

Revenue CAGR 3Y

−8.63%

EPS CAGR 3Y

+0.00%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

1.04x

Current Ratio

0.50x

Quick Ratio

0.29x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.14B

Net Income (TTM)

−135.01M

Op. CF (TTM)

−13.35M

Latest newsMore news →

Changmao Biochemical Engineering announced its interim results for the six months ended June 2026, with revenue of RMB 290 million, up 6.3% year-on-year, and a narrowed net loss of RMB 4.932 million compared to a loss of RMB 25.79 million in the same period last year.18d ago

Similar companies

Wai Chun Bio-Technology Limited00660.HK FutureFuel Corp.FF Ko Yo Chemical (Group) Limited00827.HK Zhejiang Chang'an Renheng Technology Co., Ltd.08139.HK AdvanSix Inc.ASIX Valhi, Inc.VHI Find similar companies →

Latest newsMore news →

Changmao Biochemical Engineering announced its interim results for the six months ended June 2026, with revenue of RMB 290 million, up 6.3% year-on-year, and a narrowed net loss of RMB 4.932 million compared to a loss of RMB 25.79 million in the same period last year.18d ago